Characteristic | Proportion of pregnancy under the protection of IRS | ||
---|---|---|---|
None (n = 134) | >0–20 % (n = 90) | >20–43 % (n = 65) | |
Malaria parasites detected at enrolment, n (%) | 76 (56.7Â %) | 52 (57.8Â %) | 39 (60.0Â %) |
Age at enrolment in years, mean (SD)a | 21.1 (3.9) | 22.9 (4.0) | 22.6 (4.0) |
Gravidity, n (%)a | |||
 1 | 64 (47.8 %) | 23 (25.6 %) | 16 (24.6 %) |
 2 | 37 (27.6 %) | 25 (27.8 %) | 25 (38.5 %) |
 >3 | 33 (24.6 %) | 42 (46.7 %) | 24 (36.9 %) |
Study drugs started at 16 vs 20Â weeks GA, n (%)a | 61 (45.5Â %) | 85 (94.4Â %) | 57 (87.7Â %) |
Assigned IPTp arm, n (%) | |||
 3-dose SP | 45 (33.6 %) | 34 (37.8 %) | 23 (35.4 %) |
 3-dose DP | 41 (30.6 %) | 26 (28.9 %) | 22 (33.9 %) |
 Monthly DP | 48 (35.8 %) | 30 (33.3 %) | 20 (30.8 %) |
Maternal weight gain during pregnancy, mean kg/week (SD) | 0.25 (0.15) | 0.25 (0.12) | 0.24 (0.15) |
Household wealth index, n (%) | |||
 Lowest tertile | 45 (33.6 %) | 34 (37.8 %) | 20 (30.8 %) |
 Middle tertile | 45 (33.6 %) | 23 (25.6 %) | 27 (41.5 %) |
 Highest tertile | 44 (32.8 %) | 33 (36.7 %) | 18 (27.7 %) |